{"id":468,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2015-02-18","marketCap":1604.873779296875,"name":"Rocket Pharmaceuticals Inc","phone":"16464409100.0","outstanding":89.97000122070312,"symbol":"RCKT","website":"https://www.rocketpharma.com/","industry":"Biotechnology"},"price":20.51,"year":2023,"month":11,"day":7,"weekday":"Tuesday","title":"Performance Analysis of Rocket Pharmaceuticals Inc and Competitors","date":"2023-11-07","url":"/posts/2023/11/07/RCKT","content":[{"section":"Company Background","text":"Rocket Pharmaceuticals Inc is a biotechnology company that focuses on the development of gene therapies. It specializes in using lentiviral vectors for the treatment of rare and devastating pediatric diseases. The company's competitors in the industry include other biotechnology firms involved in gene therapy research and development."},{"section":"Stock Performance Overview","text":"Rocket Pharmaceuticals Inc stock has shown [performance] in comparison to its competitors. [Justification of performance can be provided]."},{"section":"Financial Performance","text":"Analyzing the financial performance of Rocket Pharmaceuticals Inc and its competitors reveals [performance details]. [Comparison of financial metrics and trends can be discussed]."},{"section":"Clinical Trials and Pipeline","text":"Assessing the clinical trials and pipeline of Rocket Pharmaceuticals Inc and its competitors showcases [relevant information about ongoing trials, success rates, or promising therapies]. [Comparison of pipeline strength and potential can be discussed]."},{"section":"Market Share and Competitive Position","text":"Examining the market share and competitive position of Rocket Pharmaceuticals Inc and its competitors reveals [relevant data on market share, growth, or competitive advantages]. [Comparison of market presence and positioning can be discussed]."},{"section":"Recent News and Developments","text":"Reviewing the recent news and developments of Rocket Pharmaceuticals Inc and its competitors highlights [recent announcements, partnerships, or breakthroughs]. [Comparison of recent developments and impact can be discussed]."},{"section":"Risks and Challenges","text":"Identifying the risks and challenges faced by Rocket Pharmaceuticals Inc and its competitors includes [potential regulatory hurdles, clinical trial setbacks, or competition]. [A discussion of common risks and challenges in the industry can be provided]."},{"section":"Conclusion","text":"Overall, the performance of Rocket Pharmaceuticals Inc stock in comparison to its competitors in the same industry [conclusion statement]. [Closing remarks on the industry's potential or future outlook can be included]."}],"tags":["CrossOver100","Long","Biotechnology"],"news":[{"category":"company","date":1699304640,"headline":"Rocket Pharmaceuticals Reports Third Quarter 2023 Financial Results and Highlights Recent Progress","id":123671271,"image":"https://media.zenfs.com/en/business-wire.com/8cad7b6ccb2783af361cb179b3df8da1","symbol":"RCKT","publisher":"Yahoo","summary":"CRANBURY, N.J., November 06, 2023--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare disorders with high unmet need, today reported financial results for the quarter ending September 30, 2023, and updates from the Companyâ€™s key pipeline developments, business operations and upcoming milestones.","url":"https://finance.yahoo.com/news/rocket-pharmaceuticals-reports-third-quarter-210400702.html"},{"category":"company","date":1699287300,"headline":"Rocket Pharmaceuticals: Q3 Earnings Snapshot","id":123675785,"image":"","symbol":"RCKT","publisher":"Associated Press, The","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=9lt36ylhq6"},{"category":"company","date":1699253880,"headline":"Rocket Pharmaceuticals (RCKT) Receives a Buy from TD Cowen","id":123675787,"image":"","symbol":"RCKT","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3198692066"},{"category":"company","date":1699246200,"headline":"Rocket Pharmaceuticals GAAP EPS of -$0.75 beats by $0.07","id":123675788,"image":"","symbol":"RCKT","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3198436483"},{"category":"company","date":1699240380,"headline":"Rocket Pharmaceuticals reports Q3 EPS (75c), consensus (81c)","id":123675789,"image":"","symbol":"RCKT","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3198250608"},{"category":"company","date":1699187400,"headline":"With This Rally, Rocket Just Might Take Off","id":123647310,"image":"","symbol":"RCKT","publisher":"Yahoo","summary":"Let me tell you why I and how I added this biotech name, and look at the bigger picture of the market and economy.  Despite good news on a myriad of fronts, the stock was clearly swimming upstream as the biotech sector sold off hard over the past few months.  This gene therapy developer garnered a priority review from the Food and Drug Administration early in October for its marketing application for potentially its first approved product, a candidate to treat Leukocyte Adhesion Deficiency-I, a rare immune disorder in children.","url":"https://finance.yahoo.com/m/4199b196-82d6-3fef-9753-df2d5cadd804/with-this-rally%2C-rocket-just.html"},{"category":"company","date":1698963960,"headline":"Rocket Pharmaceuticals Stock Sees Improved Price Strength","id":123583560,"image":"https://media.zenfs.com/en/ibd.com/62147566276b3a75eab1ea938001a116","symbol":"RCKT","publisher":"Yahoo","summary":"Rocket Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating","url":"https://finance.yahoo.com/m/9337942c-556e-34e5-8428-4f5d664871b8/rocket-pharmaceuticals-stock.html"},{"category":"company","date":1698887940,"headline":"Rocket Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for RCKT","id":123623131,"image":"","symbol":"RCKT","publisher":"Market News Video","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3191829040"},{"category":"company","date":1698859260,"headline":"WestRock Co. stock rises Wednesday, still underperforms market","id":123564121,"image":"https://images.mktw.net/im-220105/social","symbol":"RCKT","publisher":"MarketWatch","summary":"Shares of WestRock Co. inched 0.72% higher to $36.19 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S\u0026P...","url":"https://www.marketwatch.com/data-news/westrock-co-stock-rises-wednesday-still-underperforms-market-20b00a8b-059dfbcef37e"},{"category":"company","date":1698772800,"headline":"WestRock Co. stock outperforms market on strong trading day","id":123564123,"image":"https://images.mktw.net/im-220105/social","symbol":"RCKT","publisher":"MarketWatch","summary":"Shares of WestRock Co. rose 1.41% to $35.93 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S\u0026P 500 Index...","url":"https://www.marketwatch.com/data-news/westrock-co-stock-outperforms-market-on-strong-trading-day-0a5f337f-5dd4b5ca1bbe"},{"category":"company","date":1698686400,"headline":"WestRock Co. stock rises Monday, still underperforms market","id":123508683,"image":"https://images.mktw.net/im-220105/social","symbol":"RCKT","publisher":"MarketWatch","summary":"Shares of WestRock Co. inched 0.65% higher to $35.43 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S\u0026P...","url":"https://www.marketwatch.com/data-news/westrock-co-stock-rises-monday-still-underperforms-market-7d5803e9-53ca36e73ea4"},{"category":"company","date":1698432540,"headline":"Rocket Pharmaceuticals Stock Sees RS Rating Pops Higher","id":123467287,"image":"","symbol":"RCKT","publisher":"Yahoo","summary":"A Relative Strength Rating upgrade for Rocket Pharmaceuticals shows improving technical performance. Will it continue?","url":"https://finance.yahoo.com/m/6590f755-75a5-3cad-bc7c-5080163468f3/rocket-pharmaceuticals-stock.html"},{"category":"company","date":1698427200,"headline":"WestRock Co. stock falls Friday, still outperforms market","id":123486702,"image":"https://images.mktw.net/im-220105/social","symbol":"RCKT","publisher":"MarketWatch","summary":"Shares of WestRock Co. dropped 0.11% to $35.20 Friday, on what proved to be an all-around poor trading session for the stock market, with the S\u0026P 500 Index...","url":"https://www.marketwatch.com/data-news/westrock-co-stock-falls-friday-still-outperforms-market-fa27a70b-bb4c5d62f61c"},{"category":"company","date":1698340800,"headline":"WestRock Co. stock rises Thursday, outperforms market","id":123486703,"image":"https://images.mktw.net/im-220105/social","symbol":"RCKT","publisher":"MarketWatch","summary":"Shares of WestRock Co. rose 1.76% to $35.24 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S\u0026P 500 Index...","url":"https://www.marketwatch.com/data-news/westrock-co-stock-rises-thursday-outperforms-market-8d20979d-4e22c6139fea"},{"category":"company","date":1698254460,"headline":"WestRock Co. stock falls Wednesday, still outperforms market","id":123486704,"image":"https://images.mktw.net/im-220105/social","symbol":"RCKT","publisher":"MarketWatch","summary":"Shares of WestRock Co. slid 0.26% to $34.63 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S\u0026P 500 Index...","url":"https://www.marketwatch.com/data-news/westrock-co-stock-falls-wednesday-still-outperforms-market-1429c627-a8778ffb0f2c"},{"category":"company","date":1698168060,"headline":"WestRock Co. stock outperforms competitors on strong trading day","id":123486705,"image":"https://images.mktw.net/im-220105/social","symbol":"RCKT","publisher":"MarketWatch","summary":"Shares of WestRock Co. rallied 2.81% to $34.72 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S\u0026P 500...","url":"https://www.marketwatch.com/data-news/westrock-co-stock-outperforms-competitors-on-strong-trading-day-632ef6b1-a66f002de2ca"},{"category":"company","date":1698159577,"headline":"Cantor Fitzgerald Initiates Coverage of Rocket Pharmaceuticals (RCKT) with Overweight Recommendation","id":123361775,"image":"","symbol":"RCKT","publisher":"Fintel","summary":"","url":"https://fintel.io/news/cantor-fitzgerald-initiates-coverage-of-rocket-pharmaceuticals-rckt-with-overweight-recommendation-423"},{"category":"company","date":1698136920,"headline":"Cantor Fitzgerald biotech analyst holds an analyst/industry conference call","id":123367857,"image":"","symbol":"RCKT","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3175173269"},{"category":"company","date":1698110400,"headline":"Rocket Pharma gains as Cantor sees $65 price target","id":123377605,"image":"","symbol":"RCKT","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3175578892"}]}